WOBURN, Mass. (October 27, 2025) – Swiss biopharmaceutical developer SQ Innovation has expanded its U.S. operations with a 2,300-square-foot lease at Tower Office Park, in Woburn. The new satellite facility, designated for light manufacturing and administrative functions, will complement the firm’s primary American operation in Burlington.
Founded in 2019, SQ Innovation develops novel therapies for subcutaneous drug delivery, aiming to support at-home treatment for conditions traditionally managed in hospital settings. The company’s Lasix ONYU, designed to treat fluid overload due to worsening heart failure, received U.S. FDA approval on October 7.
In addition to its Woburn and Burlington sites, SQ Innovation maintains operations in Switzerland and The Netherlands.
Cummings Properties senior leasing director Mike Truesdale worked with Jason Rexinis, of Colliers, on the Woburn lease.
“We have a strong history with Jason and the Colliers team,” said Truesdale. “They understand the strength and flexibility of our portfolio, which allows us to deliver specialized, high-value spaces that align with each client’s unique operational needs.”
According to Truesdale, Tower Office Park offered the ideal combination of size, functionality, and convenience.
“Cummings’ diverse portfolio allows us to offer high-value space that’s the right size for the right use,” said Truesdale. “This Tower Office Park location provides private loading, convenient highway access via I-93 and I-95, and close proximity to SQ Innovation’s Burlington facility—all key factors for a growing life sciences firm.”
Cummings Properties’ 11 million square feet of commercial real estate accommodates labs and clean rooms, offices, healthcare facilities, behavioral health centers, restaurants, retail storefronts, warehouses, executive suites, and more. With a portfolio of this size and variety, the firm can meet virtually any commercial real estate need. Its in-house experts in design, construction, and property management offer “one-stop shopping” for the business community. More information is available at www.cummings.com.
SQ Innovation, Inc. is a privately held Swiss biopharmaceutical company founded to develop and commercialize innovative, cost-effective therapies for subcutaneous delivery, enabling at-home treatment for conditions that are usually managed during hospitalizations. Additional information is available at sqinnovation.com.
.